Goodrx may not be as innocent as it makes itself appear, the FTC is making it pay up as a result

Digital privacy in modern times is almost as important as any other part of your daily life. For GoodRx apparently nobody got that memo according to an announcement from the Federal Trade Commission. According to the FTC, the company has to pay a $1.5m fine and immediately implement proper data privacy practices.

The FTC found that the company had wrongfully been collecting user data; tracking data, and other health data and then coincidentally sending it to data brokers for advertising purposes.

“Digital health companies and mobile apps should not cash in on consumers’ extremely sensitive and personally identifiable health information,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “The FTC is serving notice that it will use all of its legal authority to protect American consumers’ sensitive data from misuse and illegal exploitation.”